Similar articles

• Increased production of prostaglandin D2 in patients with systemic mastocytosis.

  Roberts LJ 2nd, Sweetman BJ, Lewis RA, Austen KF, Oates JA. Roberts LJ 2nd, et al. N Engl J Med. 1980 Dec 11;303(24):1400-4. doi: 10.1056/NEJM198012113032405. N Engl J Med. 1980. PMID: 6107852 No abstract available.
• The flush syndrome: an expression of systemic mastocytosis with increased prostaglandin D2 production.

  Kootte AM, Haak A, Roberts LJ. Kootte AM, et al. Neth J Med. 1983;26(1):18-20. Neth J Med. 1983. PMID: 6572798 No abstract available.
• Markedly increased synthesis of prostaglandin D2 in systemic mastocytosis.

  Roberts LJ 2nd, Sweetman BJ, Lewis RA, Folarin VF, Austen KF, Oates JA. Roberts LJ 2nd, et al. Trans Assoc Am Physicians. 1980;93:141-7. Trans Assoc Am Physicians. 1980. PMID: 7245571 No abstract available.
• [Mastocytosis].

  Naranjo R. Naranjo R. Med Clin (Barc). 1984 Dec 1;83(18):770-6. Med Clin (Barc). 1984. PMID: 6394921 Review. Spanish. No abstract available.
• [Prostaglandin J2--anti-tumor activity and mechanism of action].

  Fukushima M. Fukushima M. Nihon Rinsho. 1988 Apr;46(4):943-51. Nihon Rinsho. 1988. PMID: 3043050 Review. Japanese. No abstract available.